RxDoctor Payments Data

John Jasinski

Medical · Norwalk, CTNPI 1598781791

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $145,777 of the $185,159 with a category attached, or 78.7%. 29 manufacturers reported payments, led by Johnson & Johnson at 31.2% of the total. 2025 is the largest year on record at $64,535, 5.9 times the $10,849 reported in 2021. Among medical clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$185,159in general payments, 2019–2025

Across 1,186 payments — averaging $156.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$58K
  • Incyte Corporation$36K
  • UCB, Inc.$33K
  • AbbVie$17K
  • Janssen Scientific Affairs, LLC$15K
  • Sun Pharmaceutical Industries Inc.$9K
  • plus $17K from 23 others

What the payments were for

  • Consulting fees$4,6052%
  • Speaking & faculty fees$145,77779%
  • Travel & lodging$9,3715%
  • Food & beverage$25,00014%
  • Education$4060%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$185,159 in reported general payments places this provider in the 95th percentile of 592 medical providers in Connecticut.

See all medical providers in Connecticut

Medicare billing

Part B allowed, 2024
$222,805
Medicare patients
760
Services billed
3,828

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab25$93,750
Dupixent PenDupilumab22$86,393
Doxycycline Hyclate35$3,791
Halobetasol Propionate84$3,530
Ketoconazole160$2,606
Triamcinolone Acetonide150$2,269
Minoxidil112$1,689
Clobetasol Propionate41$1,555
Metronidazole20$1,128
Ciclopirox48$1,037
Fluorouracil16$964
Mometasone Furoate88$878
Cephalexin40$834
Clindamycin Phosphate31$828
ValacyclovirValacyclovir Hcl24$579

Paid to pharmacies, not to this prescriber.

Other medical in Norwalk

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →